Search

Your search keyword '"Peritoneal Fibrosis prevention & control"' showing total 135 results

Search Constraints

Start Over You searched for: Descriptor "Peritoneal Fibrosis prevention & control" Remove constraint Descriptor: "Peritoneal Fibrosis prevention & control"
135 results on '"Peritoneal Fibrosis prevention & control"'

Search Results

1. Caffeic acid phenethyl ester restores mitochondrial homeostasis against peritoneal fibrosis induced by peritoneal dialysis through the AMPK/SIRT1 pathway.

2. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization.

3. JPH203 alleviates peritoneal fibrosis via inhibition of amino acid-mediated mTORC1 signaling.

4. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis.

5. Protective effect of Cyclo(His-Pro) on peritoneal fibrosis through regulation of HDAC3 expression.

6. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.

7. Preventive effect of culture supernatant of epithelial-like peritoneal mesothelial cells on peritoneal fibrosis.

8. Melatonin decreases GSDME mediated mesothelial cell pyroptosis and prevents peritoneal fibrosis and ultrafiltration failure.

9. Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho.

10. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway.

11. Magnesium inhibits peritoneal calcification as a late-stage characteristic of encapsulating peritoneal sclerosis.

12. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.

13. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.

14. Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis.

15. Inflammatory chemokine (C-C motif) ligand 8 inhibition ameliorates peritoneal fibrosis.

16. Epigallocatechin gallate prevents peritoneal fibrosis by inhibiting epithelial-mesenchymal transition in human peritoneal mesothelial cells.

17. Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization.

18. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats.

19. Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice.

20. Astragalus Total Saponins Ameliorate Peritoneal Fibrosis by Promoting Mitochondrial Synthesis and Inhibiting Apoptosis.

21. Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression.

22. An inhibitor of Krüppel-like factor 5 suppresses peritoneal fibrosis in mice.

23. Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis.

24. A disposable, ultra-fine endoscope for non-invasive, close examination of the intraluminal surface of the peritoneal dialysis catheter and peritoneal cavity.

25. Therapeutic effect of 1,25(OH)2-VitaminD3 on fibrosis and angiogenesis of peritoneum induced by chlorhexidine.

26. Valsartan ameliorates high glucose-induced peritoneal fibrosis by blocking mTORC1 signaling.

27. Complement system activation and peritoneal membrane alterations: Culprit or innocent bystander?

28. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.

29. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.

30. Delayed administration of suramin attenuates peritoneal fibrosis in rats.

31. Comparison of anti-peritoneal fibrotic effects between an mTORC1-specific blocker and a PI3K/mTOR dual-blocker.

32. Protective effects and mechanisms of omega-3 polyunsaturated fatty acid on intestinal injury and macrophage polarization in peritoneal dialysis rats.

33. Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy.

34. After peritoneal dialysis discontinuation: When will we remove peritoneal dialysis catheter?

35. Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal.

36. Apigenin suppresses mouse peritoneal fibrosis by down-regulating miR34a expression.

37. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

38. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.

39. Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation.

40. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.

41. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.

42. Current Status of Peritoneal Dialysis in Japan.

43. Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis.

44. Astragalus Inhibits Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells by Down-Regulating β-Catenin.

45. Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis.

46. Targeting lysyl oxidase reduces peritoneal fibrosis.

47. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.

48. Peritoneal Membrane Preservation.

49. Encapsulating Peritoneal Sclerosis.

50. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.

Catalog

Books, media, physical & digital resources